Keytruda
Recently, concerns have emerged in India over a black market for Keytruda, driven by high costs and limited access.
- Keytruda is the brand name of pembrolizumab, an advanced cancer immunotherapy drug.
- Developed by Merck & Co., it is among the world’s top-selling cancer drugs.
- It belongs to a class called checkpoint inhibitors, which enhance immune response against cancer.
- Works by blocking PD-1 receptors on T-cells, preventing cancer cells from evading immune detection.
- Enables the body’s immune system to identify and destroy cancer cells more effectively.
- Used to treat cancers like lung, melanoma, cervical, kidney, and certain breast cancers.
- Unlike chemotherapy, ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Reusable Rocket Stage Recovery by China
- 2 Bio-Inspired Coating for 3D-Printed Bone Implants
- 3 IUCAA Discovers X-ray Binary System in Magellanic Bridge
- 4 IARC Classifies Three Common Medicines as Group 1 Carcinogens
- 5 Moken Sea Nomads and Underwater Vision
- 6 India’s First Indigenous African Swine Fever Vaccine
- 7 800 kN FFSC Rocket Engine
- 8 Mandatory Vehicle-to-Vehicle Communication
- 9 Thunderquakes: Using Thunder to Map the Earth’s Subsurface
- 10 AI Designs Complete Viral Genomes to Fight Drug-Resistant Bacteria

